Old Web
English
Sign In
Acemap
>
authorDetail
>
Lotus Investigators
Lotus Investigators
Clinical endpoint
Placebo
Medicine
Dermatology Life Quality Index
Ustekinumab
2
Papers
60
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.
2021
Breast Cancer Research and Treatment
Rebecca Dent
Mafalda Oliveira
Steven J. Isakoff
Seock-Ah Im
Marc Espié
Sibel Blau
Antoinette R. Tan
Cristina Saura
Matthew Wongchenko
N. Xu
Denise Bradley
Sarah-Jayne Reilly
Aruna Mani
Sung-Bae Kim
Lotus Investigators
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS).
2013
Journal of Drugs in Dermatology
Zhu X
Zheng M
Song M
Shen Yk
Chan D
Szapary Po
Wang B
Lotus Investigators
Show All
Source
Cite
Save
Citations (60)
1